# MEDROXYPROGESTERONE ACETATE
> **ANDA212844** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-08-31
## Drug
- **FDA Application Number:** ANDA212844
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEDROXYPROGESTERONE ACETATE
- **Generic name:** MEDROXYPROGESTERONE ACETATE
- **Active ingredients:** MEDROXYPROGESTERONE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Eugia US LLC
- **First approval:** 2022-08-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212844)
---
*MORVS · CC0 1.0*